Lixte Biotechnology Holdings Inc (LIXT)
2.38
+0.09
(+3.93%)
USD |
NASDAQ |
May 16, 16:00
2.40
+0.02
(+0.84%)
After-Hours: 20:00
Lixte Biotechnology Holdings Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2016 | 0.00 |
| September 30, 2016 | 1.054M |
| June 30, 2016 | -0.1834M |
| March 31, 2016 | -0.7667M |
| December 31, 2015 | 0.42M |
| September 30, 2015 | 0.60M |
| June 30, 2015 | 0.1927M |
| March 31, 2015 | -1.103M |
| December 31, 2014 | 0.68M |
| September 30, 2014 | 0.30M |
| June 30, 2014 | -1.188M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | -0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.075M |
| March 31, 2012 | 0.27M |
| December 31, 2011 | 0.45M |
| September 30, 2011 | 0.50M |
| Date | Value |
|---|---|
| June 30, 2011 | 0.30M |
| March 31, 2011 | -0.00 |
| December 31, 2010 | 0.1998M |
| September 30, 2010 | 0.2743M |
| June 30, 2010 | -0.0001M |
| March 31, 2010 | -2.05M |
| December 31, 2009 | -0.025M |
| September 30, 2009 | 0.00 |
| June 30, 2009 | 0.00 |
| March 31, 2009 | 0.00 |
| December 31, 2008 | 0.00 |
| September 30, 2008 | 0.00 |
| June 30, 2008 | 0.00 |
| March 31, 2008 | 0.00 |
| December 31, 2007 | 0.00 |
| September 30, 2007 | 0.00 |
| June 30, 2007 | 0.00 |
| March 31, 2007 | -0.0003M |
| December 31, 2006 | -0.0003M |
| September 30, 2006 | -0.00 |
| June 30, 2006 | 0.00 |
| March 31, 2006 | -0.0002M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| iBio Inc | 0.00 |
| PAVmed Inc | -0.183M |
| PDS Biotechnology Corp | -- |
| Moleculin Biotech Inc | -- |
| Syros Pharmaceuticals Inc | 1.522M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.7892M |
| Free Cash Flow | -3.811M |
| Free Cash Flow Per Share (Quarterly) | -0.3509 |
| Free Cash Flow Yield | -77.70% |